13F HOLDINGS REPORT
AH CAPITAL MANAGEMENT, L.L.C.
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001415889-25-021833
Total Value
$312.9M
Positions
10
Other Managers
0
Confidential Omitted
No
Holdings (10)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | REVOLUTION MEDICINES INC | RVMDW | 2,748,523 | $101.1M | 32.32% |
| 2 | OMADA HEALTH INC | OMDA | 4,614,574 | $84.4M | 26.99% |
| 3 | BLOCK INC | BSQKZ | 1,016,697 | $69.1M | 22.07% |
| 4 | MAZE THERAPEUTICS INC | MAZE | 1,702,225 | $20.9M | 6.67% |
| 5 | BIOAGE LABS INC | BIOA | 3,233,170 | $13.4M | 4.27% |
| 6 | NAUTILUS BIOTECHNOLOGY INC | NAUT | 17,653,917 | $12.8M | 4.09% |
| 7 | ERASCA INC | ERAS | 2,862,500 | $3.6M | 1.16% |
| 8 | OPENDOOR TECHNOLOGIES INC | OPENZ | 6,200,821 | $3.3M | 1.06% |
| 9 | CAMP4 THERAPEUTICS CORP | CAMP | 2,125,339 | $3.1M | 0.98% |
| 10 | GINKGO BIOWORKS HOLDINGS INC | DNABW | 108,568 | $1.2M | 0.39% |